Concepedia

Publication | Open Access

Phase 2 trial of T-cell activation using MVI-816 and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC)

DOIFull Paper Access

47

Citations

33

References

2022

Year

Douglas G. McNeel, Jens C. Eickhoff, Ellen Wargowski, Laura E. Johnson, Christos E. Kyriakopoulos, Hamid Emamekhoo, Joshua M. Lang, Mary Jane Brennan, Glenn Liu
Journal for ImmunoTherapy of Cancer

Abstract

NCT02499835.

References

YearCitations

Page 1